This statistic displays the top oncology products worldwide by projected market share for 2024, and their market shares in 2017. Cancer drug Opdivo from Bristol-Myers Squibb and Ono Pharmaceutical is expected to keep its position with a market share of five percent.
Top oncology products
Oncological products generate a significant proportion of their revenue in the United States and in Europe. In 2012, oncology spending totaled nearly 50 billion U.S. dollars in the United States and 22 billion U.S. dollars in the leading five EU-countries. Oncology is among the top therapy classes in the pharmaceutical market.
Among the top oncology products in 2017 were Keytruda and Opdivo, generating 3.8 and 5.7 billion U.S. dollars on the worldwide market. Top cancer drug Rituxan is marketed by Roche and is used to treat diseases such as lymphomas, leukemias, transplant rejections, and autoimmune disorders. Bevacizumab, marketed as Avastin also under Roche, is used to slow down the growth rate of new blood vessels. It can be used to treat cancers such as those originating in the colorectum, lung, breast, or kidney. Roche has a stronghold on the global oncology market. In 2017, Roche maintained a share of over 26 percent of the market but is expected to drop to some 12 percent of the market in 2024. Roche or Hoffman-La Roche is a Swiss company that was founded in 1896. The company focuses primarily on pharmaceutical products and diagnostics. Roche generated more than 53 billion Swiss francs in revenue in 2017, making it one of the most successful biotech and pharmaceutical companies in the world.
Top 5 oncology products worldwide by market share in 2017 and 2024
Oncology includes: Alkaloids, alkylating agents, anti-metabolites, anti-neoplastic MAbs, cancer vaccines, cytotoxic antibiotics, cormone therapies, platinum compounds and other anti-cancer. Excludes anti-emetics and anti-anaemics used in chemotherapy-induced anaemia. Also excludes: Interferons, immunostimulants & immunosuppressants.
The products are ranked by 2024 market share.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Evaluate. (June 6, 2018). Top 5 oncology products worldwide by market share in 2017 and 2024 [Graph]. In Statista. Retrieved September 24, 2023, from https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/
Evaluate. "Top 5 oncology products worldwide by market share in 2017 and 2024." Chart. June 6, 2018. Statista. Accessed September 24, 2023. https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/
Evaluate. (2018). Top 5 oncology products worldwide by market share in 2017 and 2024. Statista. Statista Inc.. Accessed: September 24, 2023. https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/
Evaluate. "Top 5 Oncology Products Worldwide by Market Share in 2017 and 2024." Statista, Statista Inc., 6 Jun 2018, https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/
Evaluate, Top 5 oncology products worldwide by market share in 2017 and 2024 Statista, https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/ (last visited September 24, 2023)
Top 5 oncology products worldwide by market share in 2017 and 2024 [Graph], Evaluate, June 6, 2018. [Online]. Available: https://www.statista.com/statistics/309718/global-top-oncology-products-market-share-projection/